As a healthcare provider evaluating patients traveling to Spain, what specific communicable diseases and assessments must I review to certify, per the International Health Regulations (2005), that they do not have any condition that could cause serious public‑health repercussions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Certification Requirements for International Health Regulations (2005) Compliance

For students traveling to Spain, you must verify they do not have active tuberculosis, infectious diarrheal diseases (cholera, typhoid), or other communicable diseases that pose serious public health risks as defined by the International Health Regulations (2005). 1, 2

Core Screening Requirements

The IHR (2005) focuses on diseases that can cause "public health emergencies of international concern" (PHEIC). While the regulations moved away from fixed disease lists, certain conditions remain critical for certification:

Essential Assessments

Active Tuberculosis Screening:

  • Obtain history of TB exposure, prior TB skin test status, and any respiratory symptoms (chronic cough, hemoptysis, night sweats, weight loss) 3
  • For high-risk individuals (from TB-endemic countries with ≥50 cases/100,000 population), consider tuberculin skin test (TST) or interferon-gamma release assay 4, 5
  • Active pulmonary or laryngeal TB is an absolute contraindication until proven non-infectious 4

Acute Infectious Diseases:

  • Rule out active gastroenteritis with ongoing diarrhea (potential cholera, typhoid, or other enteric pathogens) 6
  • Exclude acute febrile illnesses suggesting communicable disease 7
  • Screen for symptoms of respiratory infections that could indicate influenza or other transmissible pathogens 4, 6

Vaccine-Preventable Diseases:

  • Verify measles-mumps-rubella immunity (particularly measles, which remains highly transmissible) 8, 4
  • Confirm up-to-date status for routine vaccinations including tetanus-diphtheria-pertussis 4, 9
  • Document any required yellow fever vaccination if traveling from endemic areas 1

Specific Clinical Evaluation

History to Obtain:

  • Recent fever, rash, or respiratory symptoms 4
  • Recent exposure to individuals with TB, pertussis, measles, or varicella 4
  • History of chronic infectious diseases (HIV, hepatitis B/C) that could pose transmission risk 8, 5
  • Recent travel to areas with endemic diseases (malaria, dengue, other vector-borne illnesses) 6

Physical Examination Findings to Document:

  • Absence of active skin lesions suggesting contagious conditions 4
  • No signs of active respiratory infection (productive cough, respiratory distress) 3
  • No jaundice or hepatosplenomegaly suggesting acute hepatitis 6
  • No lymphadenopathy or other signs of systemic infection 6

Practical Certification Approach

You can certify the patient does NOT have diseases of public health concern if:

  1. No active tuberculosis (negative screening in high-risk individuals, no symptoms)
  2. No acute diarrheal illness or symptoms of enteric infection
  3. No active respiratory infection with fever
  4. No active hepatitis or jaundice
  5. No rash or skin lesions suggesting measles, varicella, or other contagious exanthems
  6. Routine vaccinations are current (particularly measles immunity documented)
  7. No symptoms of acute febrile illness

Common Pitfalls to Avoid:

  • Don't overlook asymptomatic TB in patients from high-prevalence countries—these students may require TST or IGRA testing before certification 5
  • Remember that some infections have incubation periods—recent travel from endemic areas requires careful questioning about exposures 6, 7
  • Chronic, stable HIV or hepatitis B/C with appropriate management does NOT constitute a public health emergency and should not prevent certification 8

Documentation Should Include:

  • Statement that patient has no active communicable disease of public health concern per IHR (2005)
  • Confirmation of vaccination status (particularly measles immunity)
  • Any relevant negative screening tests (TB screening if indicated)
  • Date of examination and your signature with credentials

The IHR (2005) emphasizes context-specific risk assessment rather than blanket exclusions 1, 10. Your role is to identify active, transmissible diseases that could spread internationally, not to exclude students with well-controlled chronic conditions.

References

Research

Adapting the implementation of clinical practice guidelines for the screening of infectious diseases and female genital mutilation/cutting in migrants in Spain.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2026

Research

Implementing the International Health Regulations (2005) in Europe.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2006

Related Questions

A 15‑month‑old child has a 2‑day history of rare, brief, middle‑pitched inspiratory noises lasting 2–3 breaths, not related to position, activity, or time of day, with mild nasal congestion but otherwise normal feeding, hydration, elimination, development, and immunizations. What is the appropriate management?
What is the recommended evaluation and management for a 19-year-old female with sudden hair loss over the past 5 days?
Should a postero‑anterior and lateral chest radiograph be obtained for a 10 mm nodular opacity in the left upper lung to differentiate a solitary nodule from a confluence of shadows?
Is a blood pressure of 146/84 mm Hg an indication to start antihypertensive medication?
How many ampoules of a 17.7% sodium solution are needed to prepare a 3% hypertonic sodium solution?
What renal diseases are associated with polymyalgia rheumatica?
What are the five most prescribed antimalarial agents and the geographic regions where each is active?
Which antimalarial agents are most commonly prescribed in Canada for prophylaxis and treatment, and in which endemic regions do they remain effective?
How do I convert a daily dose of isosorbide mononitrate to an equivalent daily dose of isosorbide dinitrate and divide it into three equal administrations?
If a patient has been on oral aripiprazole for two weeks and is tolerating it well, can I order the aripiprazole long‑acting injectable (LAI) now and administer it at the four‑week visit, maintaining the required 14‑day oral overlap?
What is the recommended erythromycin dosing regimen for adults and children, including route, dose, frequency, duration, and adjustments for hepatic impairment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.